Jamjoom Pharmaceuticals Factory Company announced regarding a Contract sign off with Local Content & Government Procurement Authority pertaining to Localization of the Pharmaceutical product Sitagliptin Phosphate for inclusion in the Mandatory List. The purpose of the agreement signed with the Local Content and Government Procurement Authority, is to include localized manufacturing of Sitagliptin Phosphate in the Mandatory list of national products. Hence, there is no financial value stipulated under the Agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
138 SAR | +4.39% | +3.76% | +20.00% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.00% | 2.47B | |
+19.64% | 43.3B | |
+24.35% | 22.22B | |
+18.92% | 15.43B | |
+20.14% | 14.48B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-10.25% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- 4015 Stock
- News Jamjoom Pharmaceuticals Factory Company
- Jamjoom Pharmaceuticals Factory Company Announces Contract Sign Off with Local Content & Government Procurement Authority